Tag Archives: Cyclophosphamide

New study shows reduced ability to regulation of the cardiovascular system in patients with ME/CFS

Kavli Trust blog post on research into ME / CFS at Haukeland University: New study shows reduced ability to regulate the cardiovascular system in patients with ME / CFS, March 26, 2021     [Google translation of a Norwegian article]   … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on New study shows reduced ability to regulation of the cardiovascular system in patients with ME/CFS

Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Norwegian rituximab trial reports negative results

The Norwegian Rituximab trial reports negative results ahead of the publication of the full results. Attempts are now under way to determine the best way forward in understanding what has been learned and how to find out which patients may still benefit from … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Norwegian rituximab trial reports negative results

The RituxME & CycloME studies – video of Dr Oystein Fluge talk

Video posted on the RME Sverige You Tube channel, 19 Nov 2016: The RituxME and CycloME studies – Ongoing Clinical Research in the ME/CFS Research Group, by Öystein Fluge, MD, Dep. Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norge … Continue reading

Posted in News | Tagged , , , , | Comments Off on The RituxME & CycloME studies – video of Dr Oystein Fluge talk

Mella finds hypometabolic state in ME/CFS

Health rising blog post, by Cort Johnson, 15 October 2016: Another Hypometabolic Signature Found Fluge and Mella are best known for their Rituximab work, but just last week Mella reported that they’d found a hypometabolic state in ME/CFS as well. … Continue reading

Posted in News | Tagged , , , , , , , , , | Comments Off on Mella finds hypometabolic state in ME/CFS

Rituximab interviews

Two Norwegian scientists, Øystein Fluge and Olav Mella, who have been researching the effects of an anti-lymphoma drug called Rituximab on people with ME/CFS, talked about their work on the BBC Radio Cambridgeshire programme ‘Naked Scientists’ on Sunday, 22 March. … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Rituximab interviews